Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Indivior

Ashley Communications celebrates 20 years of medical communications

Ashley Communications celebrates 20 years of medical communications Among this number are big pharma firmsand Merck &Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax

Cogora buys PCM Healthcare to expand its med comms footprint

Cogora buys PCM Healthcare to expand its med comms footprint PCM delivers healthcare communications and non-promotional medical education to a range of clients, including Novartis, Gilead and Indivior.

Deal Watch table for November 2014

Deal Watch table for November 2014 Vertex's CF portfolio. Royalty stream acquisition. 3, 300. Indivior  / Reckitt Benckiser.

Pharma deals during November 2014

Pharma deals during November 2014 Reckitt Benckiser(RB) is spinning out its pharma business unit, under the name Indivior. ... Indivior will not be without its challenges as sales of its off-patent opioid addiction treatment Suboxone continue to slump.

Reckitt to spin-off pharma unit as Indivior

Reckitt to spin-off pharma unit as Indivior The RB Pharmaceuticals (RBP) unit will be spun-off with a separate UK listing as Indivior, which will be UK domiciled and traded on the London Stock Exchange's main market ... If the demerger - which has the full backing of Reckitt Benckiser's board –

[ Previous 5 results ] 1 2 3

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics